Abstract
Summary‘Osmosin’ is an osmotically-controlled oral drug delivery system which presents a saturated solution of sodium indomethacin trihydrate (105.4 mg), equivalent to 8.5 mg indomethacin, to the gastro-intestinal tract at a constant rate of 7 mg per hour, with a release time of 10 to 12hours. Drug delivery is not influenced by pH or gastro-intestinal motility. The bioavailability and functionality of ‘Osmosin’ have been studied after single-dose and after repeated administrations in man. Its performance was compared to that after intravenous administration and various capsule regimens of indomethacin. In both studies, comparable urinary excretion and renal clearance for all oral regimens indicated that like amounts of drug were available for absorption from ‘Osmosin’ and ‘Indocid' capsules. This comparability was verified by the fact that indomethacin is 85% bioavailable from ‘Osmosin’ compared to intravenous or oral regimens (75 mg given as one dose of 3 × 25 mg capsules or 2-5 mg 3-times). Drug is abso...

This publication has 12 references indexed in Scilit: